Multiplexed high-throughput screening assays using RPPA



Multiplexed bioassays for cost-effective analysis of multiple biomarkers in parallel from HTS experiments or biobank sample material

Proprietary RPPA production technologies and assay knowhow for rapid customized assay setup

Multiparameter biomarker assays for uHTS small molecule and functional genomic studies using both adherent and suspension cells

Custom array production, new bioassay setup and testing

Industrial scale microarray manufacturing capacity with piloting and mass production printers, array imagers and analysis software



Eur Urol. 2016 Jun;69(6):1120-8. doi: 10.1016/j.eururo.2015.09.019

Br J Cancer. 2014 Apr 15;110(8):2072-80. doi: 10.1038/bjc.2014.113.

Mol Oncol. 2014 Feb;8(1):93-104. doi: 10.1016/j.molonc.2013.10.001.

Carcinogenesis. 2014 Jan;35(1):76-85. doi: 10.1093/carcin/bgt333.

Oncotarget. 2013 Jan;4(1):48-63.

Mol Oncol. 2013 Jun;7(3):392-401. doi: 10.1016/j.molonc.2012.10.012.

PLoS One. 2011 Feb 22;6(2):e16915. doi: 10.1371/journal.pone.0016915.

Cancer Res. 2011 Mar 1;71(5):1956-67. doi: 10.1158/0008-5472.CAN-10-2421

PLoS One. 2010 May 3;5(5):e10431. doi: 10.1371/journal.pone.0010431.

Oncogene. 2009 Nov 5;28(44):3926-36. doi: 10.1038/onc.2009.241.